SPORTS Trial Evaluation of Eluvia Drug-Eluting Stent

This document is a technical report detailing the SPORTS Trial, which is an investigator-sponsored, core-lab adjudicated, randomized controlled trial. The trial evaluates the effectiveness of drug-eluting stents (DES) compared to drug-coated balloons (DCB) and bare metal stents (BMS) in treating long superficial femoral artery (SFA) lesions. The objective of the trial is to compare angiographic and clinical outcomes among the three treatment options. The report includes key inclusion criteria for patient enrollment, which consisted of 224 participants with specific lesion characteristics. The findings indicate that the Eluvia DES demonstrated statistically superior outcomes in terms of in-lesion diameter stenosis and primary patency rates over 24 months compared to BMS and DCB. Additionally, the report discusses the high rate of bail-out stenting required in the DCB group, which did not provide additional clinical benefits. The document also outlines potential adverse events associated with the use of the Eluvia stent.